Sleep Restriction Therapy: Review of the Evidence

Rest Well Journal · Research review

Sources checked November 5, 2026 · General education for adults

Sleep restriction therapy can improve persistent insomnia, particularly the difficulty of falling asleep and staying asleep. It is a structured treatment that adjusts the time available for sleep, usually within cognitive behavioral therapy for insomnia, or CBT-I. The evidence supports its use with appropriate assessment and monitoring, while also showing why the early weeks can be challenging. [1]

The strongest guideline recommendation is for the full CBT-I treatment. Sleep restriction used alone has its own supporting research, but the two should not be treated as interchangeable. This review looks at what the studies measured, who took part, and the practical limits of their findings.

What sleep restriction therapy involves

People with insomnia sometimes spend longer in bed hoping to catch up. When much of that time is spent awake, a clinician may propose a shorter, more consistent sleep window, informed by a sleep diary. The window is reviewed and expanded as treatment progresses. The intended outcome is more consolidated sleep and an adequate, sustainable sleep opportunity. [3]

The rationale includes increasing sleep pressure and reducing extended wakefulness around sleep. Researchers continue to investigate how these mechanisms interact. A higher proportion of time in bed spent asleep can be useful, but it does not by itself show that someone is getting enough sleep. [9]

Insomnia involves sleep difficulty despite adequate opportunity to sleep. If work, caregiving or another demand is already leaving too little opportunity, further restriction is not the answer to that shortage. An assessment should distinguish these situations and look for other sleep disorders. [3]

Where the approach came from

Arthur Spielman, Paul Saskin and Michael Thorpy described sleep restriction therapy in a 1987 paper. Thirty-five people completed an eight-week program and reported improvements in several sleep measures. That early study was not a randomized comparison, so it helped introduce the approach without establishing the strength of evidence expected today. Later controlled trials and reviews provide a firmer basis for evaluating it. [5]

How guidelines place it within insomnia care

The American Academy of Sleep Medicine's 2021 guideline strongly recommends multicomponent CBT-I for adults with chronic insomnia. Its recommendation for sleep restriction as a single treatment is conditional, reflecting a less certain evidence base and the need to consider the individual situation. It recommends against sleep hygiene as the only treatment for chronic insomnia. [1]

The 2023 European guideline also recommends CBT-I first, including in-person and digital delivery. This supports asking about a complete treatment plan rather than assuming that one scheduling technique will address every part of insomnia. [6]

What the research shows

Reviews support improvements in symptoms and sleep continuity

A 2021 meta-analysis included eight randomized trials of sleep restriction used on its own. It found benefits over control conditions for insomnia severity, time taken to fall asleep, wakefulness during the night and sleep efficiency. The authors emphasized the need for longer follow-up and comparison groups that better account for treatment attention and expectations. [2]

A further meta-analysis, published online in 2025 and in a 2026 journal issue, included nine trials with 1,239 participants. Its search ended in July 2024. It also found improvements in insomnia severity and several sleep-continuity measures, while total sleep time was reduced at treatment completion. Longer-term findings were not consistent across outcomes. The reviews overlap in their underlying studies, so their participant numbers should not be added together. [7]

These results support a useful distinction: less insomnia and less broken sleep can occur before someone sleeps longer. They do not establish that shorter sleep is a desirable permanent outcome.

The HABIT trial tested delivery in primary care

The 2023 HABIT trial randomized 642 adults from 35 English general practices to four nurse-delivered sleep-restriction sessions plus a sleep-hygiene booklet, or the booklet alone. At six months, mean Insomnia Severity Index scores were 10.9 versus 13.9. The adjusted between-group difference was 3.05 points in favor of treatment, with a 95% confidence interval of 2.28 to 3.83 points. [8]

This was an average advantage on a symptom questionnaire, not a cure rate or a gain in hours asleep. The study supports delivering a brief treatment in primary care. Participants knew their group, the booklet did not match therapist contact, and fewer treatment participants provided six-month data. It did not compare sleep restriction with full CBT-I. [8]

Brief remote support may widen access

A 2025 trial randomized 147 adults to six weeks of telephone-guided sleep restriction or a sleep-diary control group. The intervention included short weekly support calls and produced a substantial improvement in insomnia severity relative to the control at treatment completion. Remission, defined as an Insomnia Severity Index score below 8, was recorded in 23 of 76 treatment participants (30%) and 2 of 71 controls (3%). [9]

Missing questionnaires were counted as non-remission, making these conservative estimates among everyone randomized. Only the treatment group was followed at three and six months, so later improvement cannot be interpreted as a controlled long-term comparison. The findings also do not show that the method is equivalent to full CBT-I. [9]

A direct comparison favors keeping the full treatment in view

A randomized trial of 150 postmenopausal women compared CBT-I, sleep restriction and sleep-hygiene education. Both active treatments improved insomnia more than education, while CBT-I showed advantages in sleep maintenance and remission. At six months, the CBT-I group reported about 40 to 43 more minutes of nightly sleep than the other groups. [10]

Those precise results apply to this population and treatment format. They are a useful reason not to promise that sleep restriction alone will provide all the benefits of a complete CBT-I course.

How to interpret the outcomes

Sleep studies often report several different results. Insomnia severity captures symptoms and their impact. Sleep onset latency estimates how long falling asleep takes. Wake after sleep onset describes wakefulness after initially falling asleep. Sleep efficiency is the proportion of time in bed spent asleep. Total sleep time asks how much sleep occurred. [2,7]

An efficiency percentage can rise because time in bed becomes shorter, even when total sleep does not increase. It needs to be read alongside sleep duration, daytime alertness and the person's experience. Diaries, questionnaires, movement-based estimates and laboratory sleep recordings also measure different aspects of sleep; a favorable result on one is not a promise of the same change on every measure. [7]

Early sleepiness deserves attention

An intensive 2014 study followed 16 people during four weeks of sleep restriction. Laboratory recordings showed reduced total sleep time early in treatment, and participants experienced more daytime sleepiness and poorer performance on a vigilance task. Sleepiness and vigilance had returned to baseline at the three-month assessment. The study was small and lacked an untreated insomnia comparison group, so it cannot establish how often these problems occur in routine care. It does demonstrate why a treatment can improve insomnia while temporarily making daytime functioning harder. [4]

HABIT recorded eight participants with serious adverse events in each group; none were judged related to treatment. That is reassuring within the trial, but it does not establish that sleep restriction is risk-free or appropriate for every reader. [8]

Do not drive or operate machinery when sleepy. Significant sleepiness, near misses or worsening functioning are reasons to contact the treating clinician promptly and review the plan, rather than push through to meet a diary target. [1,4]

Who needs an adapted plan

Discuss suitability before reducing time in bed, particularly with excessive daytime sleepiness, bipolar disorder, a seizure disorder, unstable physical or mental health, pregnancy or postpartum sleep difficulties. The 2025 VA/DoD guideline distinguishes situations requiring adaptation from those requiring delay; bipolar disorder, for example, calls for adaptation, while uncontrolled seizures call for delay. [3]

Safety-sensitive work and driving also matter. Loud snoring, witnessed breathing pauses or gasping warrant assessment for possible sleep apnea. Insomnia and apnea can coexist, so treating one does not remove the need to evaluate the other. [1,3]

These considerations are reasons to coordinate care, not reasons to conclude that every part of CBT-I is unsuitable.

Sleep compression offers a more gradual approach

Sleep compression reduces time in bed gradually. In a 2025 randomized trial of 234 adults, both compression and restriction were delivered through therapist-guided online programs. Compression produced slower and somewhat smaller insomnia improvements, with better adherence and fewer reported side effects early in treatment. [11]

The trial did not establish compression as non-inferior using its conservative comparison margin. In everyday terms, the evidence did not confirm that it preserved a sufficiently similar benefit. Compression may still be a useful option to discuss when tolerability or practical circumstances make a sharper change difficult. It remains an individualized treatment rather than a universal workaround. [11]

What a supported treatment plan should address

Before starting, ask how the provider will assess your sleep pattern, other health conditions and daytime responsibilities. A diary can help describe the pattern without requiring a perfect measurement of every awakening. The agreed plan should explain how progress will be reviewed and how the sleep window will be adjusted, including when to allow more time for sleep. [6]

Useful questions include:

Is sleep restriction appropriate for my situation, and will it be part of full CBT-I?
How will we monitor daytime sleepiness, driving safety and mood?
What should I do if I cannot safely manage the initial schedule?
What will prompt an adjustment, a different treatment approach or further assessment?
How will we decide that my sleep opportunity is sufficient?

No specific bedtime, minimum sleep window or self-adjustment formula is provided here. Those decisions need to account for individual sleep needs, safety and clinical circumstances. Medication changes should also be discussed with the prescribing clinician.

What to take from the evidence

Sleep restriction therapy has credible evidence for reducing insomnia symptoms and improving sleep continuity. Brief nurse-led and telephone-guided trials offer encouraging ways to make treatment more accessible. Full CBT-I retains the stronger overall guideline recommendation, and improvement should be judged by adequate sleep and better daily functioning as well as questionnaire scores. A plan that can be reviewed and adapted is more useful than increasingly strict rules imposed alone.

CBT-I in Depth: What Treatment Involves and the Research Behind It

Why going to bed only when sleepy can help insomnia

This article provides general education for adults and does not replace individual medical advice, diagnosis or treatment.

Sources and further reading

Sources checked November 5, 2026. Reference numbers link directly to sources.

1. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(2):255-262. doi:10.5664/jcsm.8986. Read source

2. Maurer LF, Schneider J, Miller CB, Espie CA, Kyle SD. The clinical effects of sleep restriction therapy for insomnia: a meta-analysis of randomised controlled trials. Sleep Medicine Reviews. 2021;58:101493. doi:10.1016/j.smrv.2021.101493. Read source

3. Department of Veterans Affairs and Department of Defense. Clinical Practice Guideline for the Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea. Version 3.0. 2025. See definition of chronic insomnia and Sidebar 3 on treatment components and adaptations. Read source

4. Kyle SD, Miller CB, Rogers Z, Siriwardena AN, MacMahon KM, Espie CA. Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. Sleep. 2014;37(2):229-237. doi:10.5665/sleep.3386. Read source

5. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep. 1987;10(1):45-56. doi:10.1093/sleep/10.1.45. Read source

6. Riemann D, Espie CA, Altena E, et al. The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023. Journal of Sleep Research. 2023;32(6):e14035. doi:10.1111/jsr.14035. Read source

7. Wei J, Yang F, Li C, Dong X, Liu Y. The effect of single-component sleep restriction therapy for insomnia in adults: a meta-analysis of randomised controlled trials. Journal of Sleep Research. 2026;35(3):e70200. First published online September 12, 2025. doi:10.1111/jsr.70200. Read source

8. Kyle SD, Siriwardena AN, Espie CA, et al. Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial. Lancet. 2023;402(10406):975-987. doi:10.1016/S0140-6736(23)00683-9. Read source

9. Looman MI, Blanken TF, Schoenmakers TM, et al. Telephone-guided sleep restriction for insomnia: a randomized sleep diary-controlled trial. Psychotherapy and Psychosomatics. 2025;94(3):147-161. doi:10.1159/000545138. Read source

10. Drake CL, Kalmbach DA, Arnedt JT, et al. Treating chronic insomnia in postmenopausal women: a randomized clinical trial comparing cognitive-behavioral therapy for insomnia, sleep restriction therapy, and sleep hygiene education. Sleep. 2019;42(2):zsy217. doi:10.1093/sleep/zsy217. Read source

11. Jernelöv S, Rosén A, Forsell E, et al. Is sleep compression therapy non-inferior to sleep restriction therapy? A single-blind randomized controlled non-inferiority trial comparing sleep compression therapy to sleep restriction therapy as treatment for insomnia. Sleep. 2025;48(8):zsaf093. doi:10.1093/sleep/zsaf093. Read source